Follow-The-Filings

Security · featured owners

LFCR Lifecore Biomedical Inc.

COM Equity as of 2026 Q2 among managers we track

  • 1 Owner
  • Max 10.9%
  • $17M
  • 1 reduce

Who owns this now

Largest portfolio weights among featured holders · max 10.9% (Scott Miller - Greenhaven...) · not free-float ownership

  1. Scott Miller reduce 10.9%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Scott Miller - Greenhaven Road Investment Management 2026 Q2 10.9% Reduce −9.8% 3,190,769 $17M history

1 current · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $103.27M $128.26M $128.87M
Gross profit $27.98M $41.85M $40.3M
Gross margin * 27.1% 32.6% 31.3%
Net income -$99.56M $12.01M -$38.72M
Net margin * -96.4% 9.4% -30.0%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $83.13M $81.03M $85.68M
Total non-current assets * $153.53M $172.93M $153.66M
Total assets $236.66M $253.96M $239.34M
Total current liabilities $37.4M $38.87M $30.18M
Total non-current liabilities * $125.7M $161.19M $161.73M
Total equity $35.02M $11.32M $1.34M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$17.44M -$217,000 -$206,000
Cash from investing -$4.81M -$17.92M -$6.42M
Cash from financing $39.7M $7.51M $6.42M
Net change in cash $17.45M -$10.63M -$197,000

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders